Abstract
Clinical immunoanalyzer analysis is one of the most important functions of
clinical laboratory analysis. By all accounts, automated immunoassay testing
is the most rapidly developing of the traditional clinical laboratory sectors.
Clinical immunoanalyzer analysis usually refers to determining the
concentration or activity of protein, carbohydrate, lipid, enzyme or small
molecule in easily collected body fluids, such as blood, serum, plasma or
urine. However, it is not necessarily limited to these purposes. The analysis
of virtually any biologically active substance in any place in the body can
generally be defined as clinical immunoassay testing. In fact, traditional
specialization barriers, such as microbiology, hematology, blood banking,
immunology and even anatomical pathology are fading rapidly, both
operationally and instrumentally. This TriMark Publications report deals with
the traditional scope of clinical immunoassay, while looking at the emerging
technology trends in this sector. The purpose of this study is to describe the
specific segments of the global clinical immunoanalyzer instrumentation
market. Within this area, the highly-active segments in terms of innovation
and growth are covered. Specifically, it examines the markets for small labs
and highly-automated large lab platforms, as well as the market for accessory
equipment, such as reagents and supplies. Emphasis is on those companies and
products that are actively developing and marketing immunoanalyzer products
for clinical setting, including hospitals, independent labs, physician' s
offices and clinics.
Readers can gain the following insights from this report:
- Complete analysis of the major sectors of the clinical immunoanalyzer
instrumentation market, their size, growth rates and major drivers.
- Presentation of some of the emerging technology platforms, elucidating the
potential areas that could gain traction in this market.
- Analysis of the partnerships and alliances that various key sector players
have forged, including the financing linkages of these market participants,
apart from insights into potential market collaborations.
- Examination of new technology platforms in the U.S., Japan and Europe that
seek to dominate this mature market.
| 
View Cart
